/
partner with:

SARS-CoV-2

number of breaks: 8

showing 1-5 of 8 breaks
COVID-19 during pregnancy causes fetal and placental inflammation

Pregnant women with COVID-19, the disease caused by the SARS-CoV-2 virus, are at increased risk of severe disease and mortality as well as pregnancy complications such as preeclampsia and preterm birth. COVID-19 is therefore particularly dangerous during pregnancy, as both the mother and fetus are... click to read more

  • Derek Miller | Research Associate at Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, National Institutes of Health, Bethesda, and Detroit, USA; Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, USA.
    •
  • Valeria Garcia-Flores | Assistant Professor at Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, National Institutes of Health, Bethesda, and Detroit, USA; Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, USA.
    •
  • Nardhy Gomez-Lopez | Associate Professor at Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, National Institutes of Health, Bethesda, and Detroit, USA; Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, USA.
    •
pregnancy
inflammation
coronavirus
SARS-CoV-2
immune response
Views 930
Reading time 3.5 min
published on Jul 28, 2022
Hydroxychloroquine against COVID-19? Let’s listen to monkeys!

There is no need to introduce the COVID-19 pandemic and its toll on humanity, as everyone has been affected by the coronavirus in some way. Let us go back to 2020 when it started spreading quickly, when hospitals were filling with patients that required respiratory... click to read more

  • Pauline Maisonnasse | Researcher at IDMIT, IBFJ, CEA, Fontenay-aux-Roses, France
    •
  • Roger Le Grand | Director of Research at IDMIT, IBFJ, CEA, Fontenay-aux-Roses, France
    •
COVID-19
SARS-CoV-2
hydroxychloroquine
macaque
Views 1968
Reading time 4 min
published on Oct 20, 2021
Understanding how COVID-19 Patients shed viral particles into their environment

The University of Nebraska Medical Center and Nebraska Medicine were among the first U.S. hospitals to provide care for individuals infected with the SARS-CoV-2 virus. When the first news of viral pneumonia in Wuhan, China began appearing in December of 2019, the nursing and research... click to read more

  • Joshua L. Santarpia | Associate Professor at Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA
    •
COVID-19
SARS-CoV-2
environmental contamination
Views 2822
Reading time 3.5 min
published on Jan 4, 2021
Neutralizing antibodies: the Elite Squad to combat SARS-CoV-2 infection

The rapid global transmission of SARS-CoV-2 poses a severe health emergency affecting over 20 million people worldwide as of 12 August. The research communities have taken immediate and enormous actions in search of therapeutic and prophylactic interventions. The major strategies undertaken include repurposing "old" drugs,... click to read more

  • Guanqiao Li | Research Associate at Center for Global Health and Infectious Diseases, School of Medicine and Vanke School of Public Health, Tsinghua University, Beijing, China
    •
  • Yang Liu | Research Associate at Center for Global Health and Infectious Diseases, School of Medicine and Vanke School of Public Health, Tsinghua University, Beijing, China
    •
  • Linqi Zhang | Professor at Center for Global Health and Infectious Diseases, School of Medicine and Vanke School of Public Health, Tsinghua University, Beijing, China
    •
SARS-CoV-2
neutralizing antibodies
receptor-binding domain (RBD)
Views 2376
Reading time 2.5 min
published on Nov 20, 2020
T cells: an essential but neglected component against COVID-19

The current COVID-19 pandemic has brought into our daily conversations scientific topics previously only discussed among scientists in academic environments. When the media inform us about the rise or fall of new cases of SARS-CoV-2 infection in the world, questions about immunity and protection follow... click to read more

  • Antonio Bertoletti | Professor at Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
    •
  • Anthony Tan | Senior Research Fellow at Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
    •
  • Nina Le Bert | Research Fellow at Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
    •
CoV-19
SARS-CoV-2
T cells
antiviral immunity
Views 2985
Reading time 4.5 min
published on Nov 4, 2020